Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review

OBJECTIVE: We reported a case of pathologic type transformed from adenocarcinoma to small-cell lung cancer (SCLC) after being treated with third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). MATERIALS AND METHODS: The lung cancer pathologic type was transformed fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shen, He, Yayi, Liu, Juan, Chen, Xiaoxia, Yu, Jia, Li, Wei, Chen, Bin, Sun, Chenglong, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927588/
https://www.ncbi.nlm.nih.gov/pubmed/31908495
http://dx.doi.org/10.2147/OTT.S228301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927588/
https://www.ncbi.nlm.nih.gov/pubmed/31908495
http://dx.doi.org/10.2147/OTT.S228301

Ejemplares similares